Walter M. Roufail

765 total citations
23 papers, 615 citations indexed

About

Walter M. Roufail is a scholar working on Surgery, Gastroenterology and Pathology and Forensic Medicine. According to data from OpenAlex, Walter M. Roufail has authored 23 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 9 papers in Gastroenterology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Walter M. Roufail's work include Eosinophilic Esophagitis (8 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Gastroesophageal reflux and treatments (7 papers). Walter M. Roufail is often cited by papers focused on Eosinophilic Esophagitis (8 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Gastroesophageal reflux and treatments (7 papers). Walter M. Roufail collaborates with scholars based in United States. Walter M. Roufail's co-authors include Malcolm Robinson, John P. Cello, Sanjeev Arora, S. Hanauer, Michael Safdi, Kim R. Geisinger, Julian M. Ruffin, Roberd M. Bostick, Michael J. Wargovich and Stephen J. Sontag and has published in prestigious journals such as Gastroenterology, Annals of Surgery and Radiology.

In The Last Decade

Walter M. Roufail

22 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Walter M. Roufail United States	12	295	227	185	183	88	23	615
G. O. Young South Africa	13	283 1.0×	109 0.5×	123 0.7×	155 0.8×	17 0.2×	21	572
David Limsui United States	10	121 0.4×	193 0.9×	247 1.3×	124 0.7×	214 2.4×	17	622
Piotr Krokowicz Poland	15	192 0.7×	135 0.6×	68 0.4×	57 0.3×	123 1.4×	49	714
Nanae Tsuruoka Japan	17	383 1.3×	94 0.4×	45 0.2×	296 1.6×	46 0.5×	76	908
Avegail Flores United States	12	216 0.7×	131 0.6×	375 2.0×	34 0.2×	28 0.3×	26	723
N. D. C. Finlayson United Kingdom	13	201 0.7×	45 0.2×	199 1.1×	139 0.8×	22 0.3×	34	506
Renato Sablich Italy	8	318 1.1×	63 0.3×	79 0.4×	149 0.8×	71 0.8×	19	466
M.J. Cornelius United States	9	189 0.6×	27 0.1×	424 2.3×	112 0.6×	27 0.3×	9	782
G R Gray United Kingdom	11	246 0.8×	54 0.2×	41 0.2×	83 0.5×	16 0.2×	27	544
L.S Leonardi Brazil	11	219 0.7×	100 0.4×	92 0.5×	27 0.1×	10 0.1×	38	463

Countries citing papers authored by Walter M. Roufail

Since Specialization

Citations

This map shows the geographic impact of Walter M. Roufail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter M. Roufail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter M. Roufail more than expected).

Fields of papers citing papers by Walter M. Roufail

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter M. Roufail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter M. Roufail. The network helps show where Walter M. Roufail may publish in the future.

Co-authorship network of co-authors of Walter M. Roufail

This figure shows the co-authorship network connecting the top 25 collaborators of Walter M. Roufail. A scholar is included among the top collaborators of Walter M. Roufail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter M. Roufail. Walter M. Roufail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boyapati, Sonia M., Roberd M. Bostick, Katherine A. McGlynn, et al.. (2004). Folate Intake, MTHFR C677T Polymorphism, Alcohol Consumption, and Risk for Sporadic Colorectal Adenoma (United States). Cancer Causes & Control. 15(5). 493–501. 37 indexed citations

Boyapati, Sonia M., Roberd M. Bostick, Katherine A. McGlynn, et al.. (2003). Calcium, Vitamin D, and Risk for Colorectal Adenoma. Cancer Epidemiology and Prevention Biomarkers. 12(7). 631–637. 1 indexed citations

Boyapati, Sonia M., Roberd M. Bostick, Katherine A. McGlynn, et al.. (2003). Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal anti-inflammatory drug use?. PubMed. 12(7). 631–7. 48 indexed citations

Roufail, Walter M., et al.. (2000). A woman with diarrhea, weight loss, and a gassy liver.. PubMed. 61(2). 114–6.

Sontag, Stephen J., Malcolm Robinson, Walter M. Roufail, et al.. (1997). Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi‐centre double‐blind study. Alimentary Pharmacology & Therapeutics. 11(2). 373–380. 17 indexed citations

Robinson, Malcolm, Dennis L. Decktor, Paul N. Maton, et al.. (1993). Omeprazole is superior to ranitidine plus metoclopramide in the short‐term treatment of erosive oesophagitis. Alimentary Pharmacology & Therapeutics. 7(1). 67–73. 25 indexed citations

Hanauer, S., Malcolm Robinson, Walter M. Roufail, et al.. (1993). Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.. PubMed. 88(8). 1188–97. 228 indexed citations

Roufail, Walter M., Alphonso Belsito, Malcolm Robinson, Charles F. Barish, & Abbe Rubin. (1992). Ranitidine for erosive oesophagitis: a double‐blind, placebo‐controlled study. Alimentary Pharmacology & Therapeutics. 6(5). 597–607. 31 indexed citations

Graham, David Y., Arthur J. McCullough, Stephen J. Sontag, et al.. (1990). Omeprazole versus placebo in duodenal ulcer healing. Digestive Diseases and Sciences. 35(1). 66–72. 27 indexed citations

10.

McCullough, Arthur J., David Y. Graham, Frank L. Lanza, et al.. (1989). Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing. Gastroenterology. 97(4). 860–866. 11 indexed citations

11.

Behar, José, et al.. (1987). Efficacy of Sucralfate in the Prevention of Recurrence of Duodenal Ulcers. Journal of Clinical Gastroenterology. 9. 23–30. 15 indexed citations

12.

Williams, Robert M., et al.. (1987). Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis. The American Journal of Medicine. 83(3). 61–66. 29 indexed citations

13.

Bright-Asare, Peter, et al.. (1986). Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. Digestive Diseases and Sciences. 31(S2). 63S–67S. 38 indexed citations

14.

Roufail, Walter M.. (1979). Pilot Trial of a Sulfated Polysaccharide in the Treatment of Duodenal Ulcer Disease. Southern Medical Journal. 72(3). 262–263. 3 indexed citations

15.

Roufail, Walter M.. (1978). Medical Management of Patients With Reflux Esophagitis. Southern Medical Journal. 71. 43–44. 3 indexed citations

16.

Roufail, Walter M., et al.. (1972). Esophago-pleural fistulae secondary to perforated esophageal ulcer. Gastrointestinal Endoscopy. 18(4). 165–166. 3 indexed citations

17.

Rice, Reed P., et al.. (1967). The Roentgen Diagnosis of Whipple's Disease (Intestinal Lipodystrophy). Radiology. 88(2). 295–301. 9 indexed citations

18.

Roufail, Walter M. & Julian M. Ruffin. (1966). Effect of antibiotic therapy on gluten-sensitive enteropathy. Digestive Diseases and Sciences. 11(8). 587–593. 11 indexed citations

19.

Ruffin, Julian M. & Walter M. Roufail. (1965). The diagnosis and treatment of Whipple's disease. Digestive Diseases and Sciences. 10(10). 887–891. 10 indexed citations

20.

Shingleton, William W., et al.. (1965). Comparison of Instrumentation for Experimental and Clinical Gastric Freezing. Annals of Surgery. 162(6). 1053–1056. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact